Effect of COMBO Endoscopy of Oropharyngeal Airways versus Conventional Nasal Cannula on Hypoxaemia in Obese Patients Undergoing Gastrointestinal Endoscopy under Sedation: A Randomised Controlled Trial

Abstract Background Compared with the general patient population, obese patients are more susceptible to adverse events such as hypoxaemia and airway obstruction during sedation. Furthermore, during gastrointestinal endoscopy, presence of the endoscope in the airway complicates airway management. This not only poses significant challenges for anaesthesiologists but also directly threatens patient safety. Currently, simple yet effective airway management tools specifically designed for gastroscopy in clinical practice are lacking. This study aimed to evaluate whether the use of Capnography Monitoring Bite Block Oxygenation (COMBO) endoscopy of the oropharyngeal airway could reduce the incidence of hypoxaemia and other respiratory-related adverse events compared to that with traditional nasal cannula oxygen therapy in obese patients undergoing gastrointestinal endoscopy under sedation. Methods This single-centre, prospective, randomised, single-blinded trial (1:1) included 226 adult patients with a BMI of 30–40 kg·m⁻² and an ASA physical status of I–II who were scheduled for gastrointestinal endoscopy under deep sedation with propofol–sufentanil. Participants were randomly assigned to receive either COMBO (M group) or a nasal sampling cannula (N group). Both groups received oxygen at 5–6 L·min⁻¹ with standard monitoring. The primary outcome was hypoxaemia (75% ≤ SpO₂ < 90% for ≤ 60 s). Secondary outcomes included severe hypoxaemia; airway interventions and intensity; respiratory and haemodynamic variables; anaesthetic use; procedure and recovery times; adverse events; and patient satisfaction. Results COMBO significantly reduced the incidence of hypoxaemia compared with nasal cannula (11.11% vs. 42.86%; RR, 0.26; 95% CI, 0.15–0.46; P < 0.001; NNTB, 3; 95% CI, 2–6). The airway intervention rate and intensity were also lower in the device group ( P = 0.002 and P < 0.001, respectively). Among groups M and N, group×time interactions were significant for IPI, RR, SpO₂, and PETCO₂ (all P group×time < 0.001), were borderline significant for MAP (P group = 0.044), and were nonsignificant for HR (P group×time = 0.178). Moreover, the main effects of group were significant for all the variables (all P group < 0.001). Conclusions In obese adults undergoing gastrointestinal endoscopy with sedation, the COMBO airway provides a favourable risk–benefit profile by effectively reducing the incidence of hypoxaemia and airway events and improving cardiorespiratory stability. Clinical trial registration number: NCT06590922

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-12
DOI
https://doi.org/10.21203/rs.3.rs-11383477/v1
Primary Topic
Airway Management and Intubation Techniques
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Effect of COMBO Endoscopy of Oropharyngeal Airways versus Conventional Nasal Cannula on Hypoxaemia in Obese Patients Undergoing Gastrointestinal Endoscopy under Sedation: A Randomised Controlled Trial

Chuanyu Sun, Xiaojing Liu, Qi You, Yufei Li et al.
Research Square
Airway Management and Intubation Techniques
preprint

Effect of COMBO Endoscopy of Oropharyngeal Airways versus Conventional Nasal Cannula on Hypoxaemia in Obese Patients Undergoing Gastrointestinal Endoscopy under Sedation: A Randomised Controlled Trial

Chuanyu Sun, Xiaojing Liu, Qi You, Yufei Li, Jianbo Wu, Yang Meng
preprint en

Abstract

Abstract Background Compared with the general patient population, obese patients are more susceptible to adverse events such as hypoxaemia and airway obstruction during sedation. Furthermore, during gastrointestinal endoscopy, presence of the endoscope in the airway complicates airway management. This not only poses significant challenges for anaesthesiologists but also directly threatens patient safety. Currently, simple yet effective airway management tools specifically designed for gastroscopy in clinical practice are lacking. This study aimed to evaluate whether the use of Capnography Monitoring Bite Block Oxygenation (COMBO) endoscopy of the oropharyngeal airway could reduce the incidence of hypoxaemia and other respiratory-related adverse events compared to that with traditional nasal cannula oxygen therapy in obese patients undergoing gastrointestinal endoscopy under sedation. Methods This single-centre, prospective, randomised, single-blinded trial (1:1) included 226 adult patients with a BMI of 30–40 kg·m⁻² and an ASA physical status of I–II who were scheduled for gastrointestinal endoscopy under deep sedation with propofol–sufentanil. Participants were randomly assigned to receive either COMBO (M group) or a nasal sampling cannula (N group). Both groups received oxygen at 5–6 L·min⁻¹ with standard monitoring. The primary outcome was hypoxaemia (75% ≤ SpO₂ < 90% for ≤ 60 s). Secondary outcomes included severe hypoxaemia; airway interventions and intensity; respiratory and haemodynamic variables; anaesthetic use; procedure and recovery times; adverse events; and patient satisfaction. Results COMBO significantly reduced the incidence of hypoxaemia compared with nasal cannula (11.11% vs. 42.86%; RR, 0.26; 95% CI, 0.15–0.46; P < 0.001; NNTB, 3; 95% CI, 2–6). The airway intervention rate and intensity were also lower in the device group ( P = 0.002 and P < 0.001, respectively). Among groups M and N, group×time interactions were significant for IPI, RR, SpO₂, and PETCO₂ (all P group×time < 0.001), were borderline significant for MAP (P group = 0.044), and were nonsignificant for HR (P group×time = 0.178). Moreover, the main effects of group were significant for all the variables (all P group < 0.001). Conclusions In obese adults undergoing gastrointestinal endoscopy with sedation, the COMBO airway provides a favourable risk–benefit profile by effectively reducing the incidence of hypoxaemia and airway events and improving cardiorespiratory stability. Clinical trial registration number: NCT06590922

Research Square
Shandong First Medical University (CN)
Good health and well-being
Airway Management and Intubation Techniques
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon